MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
| hmdb:HMDB0010283 ZLAXTUZQRVAWFK-PUFDHOEGSA-N | CL(20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/16:0) 1'-[1-(8Z,11Z,14Z,17Z-Eicosapentaenoyl)-2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phospho],3'-[1,2-di(9Z,12Z-octadecadienoyl)-rac-glycero-3-phospho]-glycerol 1'-[1-Eicsoate 1'-[1-Eicsoatetraenoyl-2-arachidonoyl-sn-glycero-3-phospho],3'-[1,2-dilinoleoyl-rac-glycero-3-phospho]-glycerol 1'-[1-Eicsoic acid 3-{[(2R)-2-(hexadecanoyloxy)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy(hydroxy)phosphoryl]oxy}-2-hydroxypropoxy(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propoxyphosphinic acid CL(1'-[20:4(8Z,11Z,14Z,17Z)/20:4(5Z,8Z,11Z,14Z)],3'-[18:2(9Z,12Z)/18:2(9Z,12Z)]) CL(20:4/20:4/18:2/18:2) CL(20:4N3/20:4N6/18:2N6/18:2N6) CL(20:4W3/20:4W6/18:2W6/18:2W6) CL(76:12) Cardiolipin(20:4/20:4/18:2/18:2) Cardiolipin(20:4N3/20:4N6/18:2N6/18:2N6) Cardiolipin(20:4W3/20:4W6/18:2W6/18:2W6) Cardiolipin(76:12) Cardiolipins(20:4/20:4/18:2/18:2) Cardiolipins(20:4N3/20:4N6/18:2N6/18:2N6) Cardiolipins(20:4W3/20:4W6/18:2W6/18:2W6) Cardiolipins(76:12) [3-({[(2R)-2-(hexadecanoyloxy)-3-[(9Z,12Z)-octadeca-9,12-dienoyloxy]propoxy](hydroxy)phosphoryl}oxy)-2-hydroxypropoxy][(2R)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]-3-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyloxy]propoxy]phosphinic acid |
hmdb:HMDB10283 | secondary/obsolete/fantasy identifier |